GYRE THERAPEUTICS, INC.·4

Jan 9, 4:01 PM ET

Zhang Ping 4

4 · GYRE THERAPEUTICS, INC. · Filed Jan 9, 2026

Insider Transaction Report

Form 4
Period: 2026-01-07
Zhang Ping
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-07+100,000100,000 total
    Exercise: $7.31Exp: 2036-01-07Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 100,000 shares of the Issuer's common stock, 25% of which will vest on January 7, 2027, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4